The U.S. Military HIV Research Program (MHRP)
Since its inception in 1986, MHRP at the Walter Reed Army Institute of Research (WRAIR) has emerged as a world leader in HIV vaccine research and development. In conducting the landmark RV144 Thai trial, the first, and so far only, HIV vaccine study to show modest efficacy in preventing HIV in humans, MHRP cemented its reputation in the field and formed collaborations with some of the top research institutions in the world.
Content by The U.S. Military HIV Research Program (MHRP)
|2 min read
Pre-clinical Studies Support the Army’s Pan-Coronavirus Vaccine Strategy
Recent pre-clinical studies show that SpFN COVID-19 vaccine elicits a potent immune responsePage 1 of 1
